Sickle cell disease as a paradigm of immigration hematology: New challenges for hematologists in Europe

Haematologica

Volumn 92, Issue 7, 2007, Pages 865-871

  Roberts, Irene ^a   De Montalembert, Mariane ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

AFRICA; BONE MARROW TRANSPLANTATION; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; EUROPE; FREQUENCY ANALYSIS; GENETIC DISORDER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEMOGLOBINOPATHY; HOSPITAL CARE; HUMAN; IMMIGRATION; INTERNATIONAL COOPERATION; NETHERLANDS; PHYSICIAN; PRENATAL CARE; PREVALENCE; SICKLE CELL ANEMIA; THALASSEMIA; WORLD HEALTH ORGANIZATION; HEMATOLOGY; METHODOLOGY; MIGRATION; NOTE;

ANEMIA, SICKLE CELL; EMIGRATION AND IMMIGRATION; EUROPE; HEMATOLOGY; HUMANS; PREVALENCE;

EID: 34548734657     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11474     Document Type: Editorial

References (64)

1. Weatherall D. Genomics and global health: time for a reappraisal. Science 2003;302:597-9.
2. Hagen HE, Carlstedt-Duke J. Building global networks for human diseases: genes and populations. Nat Med 2004;10: 665-7.
3. Horton R. A new global commitment to child survival. Lancet 2006;368:1041-2.
4. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull WHO 2001;79:1-15.
5. Rengelink-van der Lee JH, Schulpen TW, Beemer FA. Incidence and prevalence of hemoglobinopathies in children in The Netherlands. Ned Tijdschr Geneeskd 1995;139:1489-501.
6. Birgens H, Karle H, Guldberg P, Guttler F. Hemoglobinopathy in the county of Copenhagen. Ugeskr Laeger 1997;159:3934-9.
7. Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007; 67:39-70.
8. Montalembert M, Girot R, Galacteros F. Sickle cell disease in France 2006: results and challenges. Arch Pediatr 2006; 13:1191-4.
9. World Health Organization. Report by the Secretariat of the Fifty-ninth World Health Assembly A59/9, 2006.
10. Serjeant GR. Sickle-cell disease. Lancet 1997;350:725-30.
11. Serjeant GR. Geographic heterogeneity of sickle cell disease. In: Steinberg MH, Forget BG, Higgs DR, Nagel R, editors. Disorders of Hemoglobin. Cambridge, United Kingdom: Cambridge University Press. 2001. p. 895-905.
12. Hickman M, Modell B. Greengross P, Chapman C, Layton M, Falconer S, et al. Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. Br J Haematol 1999;104:860-7.
13. Birgens H. Screening for hemoglobinopathies at a knowledge center in Copenhagen. Resources should be allocated to solve a growing health problem in the Nordic countries. Lakartidningen 2000;97:2752-4.
14. Bardakdjian J,Wajcman H. Epidemiology of sickle cell anemia. Rev Pract 2004;54:1531-3.
15. Gulbis B, Ferster A, Cotton F, Lebouchard MP, Cochaux P, Vertongen F. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels. J Med Screen 2006;13:76-8.
16. Cela de Julian E, Dulin Iniguez E, Guerrero Soler M, Arranz Leirado M, Galaron Garcia P, Belendez Bieler C, et al. Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction. An Pediatr (Barc) 2007;66:382-6.
17. McMahon C, Callaghan CO, O'Brien D, Smith OP. The increasing prevalence of childhood sickle-cell disease in Irelenad. Ir J Med Sci 2001;170:183-5.
18. Graesdal JS, Gunderson K, Holm B, Waage A. Thalassemia and sickle-cell disease in Norway. Tidsskr Nor Laegeforen 121:678-80.
19. Dickerhof R. Sickle cell disease in Germany- disease manifestations, therapeutic options and possibilities for improvement of care. Klin Pediatr 2006;218:165-9.
20. Garcia Arias MB, Cantalejo Lopez MA, Cela de Julian, Bravo Clouzet R, Galaron Garcia P, Belendez Bieler C. Sickle cell disease: registry of the Spanish Society of Pediatric Hematology. An Pediatr (Barc) 2006;64:78-84.
21. Roberts-Harewood M, Davies SC. European register for patients with sickle cell disease treated with hyroxyurea is being set up. Br Med J 1998;317:541-2.
22. Hanchard NA, Hambleton I, Harding RM, McKenzie CA. The frequency of the sickle alele in Jamaica has not declined over the last 22 years. Br J Haematol 2005;130:939-42.
23. Akinyanju O. Control of sickle cell disorder in Africa. Nigerian J Clin Biomed Res 2006;1:24-30.
24. Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 2007;92:905-12.
25. Montalembert M, Bonnet D, Lena-Russo, Briard ML. Ethical aspects of neonatal screening for sickle cell disease in Western European countries. Acta Paediatr 2005;94:528-30.
26. Bolhuis PA, Page-Christiaens GC. The advisory report 'Neonatal screening' the Health Council of the Netherlands. Ned Tijdscr Geneesk 2005;149:2857-60.
27. Giordano PC, Plancke A, van Meir CA, Janssen CA, Kok PJ, Van Rooijen-Nijdam IH, et al. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in the Netherlands: a pilot study. Prenat Diagn 2006;26:719-24.
28. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest 2007;67:71-86.
29. Brandelise S, PinheiroV, Gabetta CS. Newborn screening for sickle cell disease in Brazil: the Campinas experience. Clin Lab Haematol 2004;26:15-9.
30. Balgir RS. The spectrum of hemoglobin variants in two scheduled tribes of Sundargarh district in north-western Orissa, India. Ann Hum Biol 2005;32:560-73.
31. Kafando E, Sawadogo M, Cotton F, Vertongen F, Gulbis B. Neonatal screening for sickle cell disease in Ouagadougou, Burkino Faso: a pilot study. J Med Screen 2005;12:112-4.
32. Masmas TN, Garly ML, Lisse IM, Rodriques A, Petersen PT, Birgens H. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study. Hemoglobin 2006; 30:355-64.
33. Njamnshi AK, Mbong EN, Wonkam A, Ongolo-Zogo P, Djientcheu VD, Sunjoh FL, et al. The epidemiology of stroke in sickle cell patients in Yaonde, Cameroon. J Neurol Sci 2006;250:79-84.
34. Mohammed AO, Attalla B, Bashir FM, Ahmed FE, El Hassan AM, Ibnauf G, et al. Relationship of the sickle gene to the ethnic and geographic groups populating the Sudan. Community Genet 2006;9:113-20.
35. Zeuner D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess 1999;3:1-186.
36. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess 2000;4:1-99.
37. Gulbis B, Tshilolo L, Cotton F, et al. Newborn screening for haemoglobinopathie: the Brussels experience. J Med Screen 1999;6:11-5.
38. Dyson SM, Culley L, Gill C. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires. Ethn Health 2006;11:169-89.
39. Lakeman P, Henneman L, Bezemer PD, Cornel MC, ten Kate LP. Developing and opitimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society. Genet Med 2006;8:502-9.
40. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatr 1988;81: 749-55.
41. Lee A, Thomas P, Cupidore L. Improved survival in homozygous sickle cell disease: lessons from a cohort study. Br Med J 1995;311:1600-2.
42. Bardakdjian-Michau J, Guilloud-Batailie M, Maier-Redelsperger M, Elion J, Girot R, Feingold J, et al. Decreased morbidity in homozygous sickle cell disease detected at birth. Hemoglobin 2002;26:211-7.
43. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-7.
44. Montalembert M. Management of children with sickle cell anemia: a collaborative work. Arch Pediatr 2002;9:1195-201.
45. Lena-Russo D, Badens C, Aubinaud M, Merono F, Paolasso C, Martini N, et al.Outcome of a school screening programme for carriers of haemoglobin disease. J Med Screen 2002;9:67-9.
46. NHS Sickle Cell and Thalassaemia Screening Programme Handbook for Laboratories. First ed., 2006).
47. American Academy of Pediatrics, Section on Hematology/Oncology Committee on genetics. Health supervision for children with sickle cell disease. Pediatrics 2002;109: 526-535.
48. Gulbis B, Ferster A, Kentos A et al. Sickle cell disease: exotic disease or a Belgian public health problem? Rev Med Brux 2005;26:S309-S13.
49. Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007;21:118-33.
50. Rahimy MC, Gangbo A, Ahouignan G, Adjou R, Deguenon C, Goussanou S, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan setting. Blood 2003;102:834-8.
51. Weatherall D, Hofman K, Rodgers G, Ruffin J, Hrynkow S. A case for developing North-South partnerships for research in sickle cell disease. Blood 2005;105:921-3.
52. Lewis R, Dixon J. Rethinking management of chronic disease. Br Med J 2004;328:220-2.
53. Grassineau D, Papa K, Ducourneau A, Duboz P, Boetsch G, Chiaroni J. Improving minority blood donations: anthropologic approach in a migrant community. Transfusion 2007;47:402-9.
54. Gelpi AP. Benign sickle cell disease in Saudi Arabia: survival estimate and population dynamics. Clin Genet 1979;15:307-10.
55. Alexander N, Higgs D, Dover G, Serjeant GR. Are there clinical phenotypes of homozygous sickle cell diisease ? Br J Haematol 2004;126:606-11.
56. Thomas AM, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. Br Med J 1982;285:633-5.
57. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-8.
58. Girot R. INSERM clinical research network on sickle cell anemia: a tool for therapeutic care and research. Arch Pediatr 1996;3 Suppl 1:321s-323s.
59. Serjeant GR, Ndugwa CM. Sickle cell disease in Uganda: a time for action. East Afr Med J 2003;80:384-7.
60. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-9.
61. Campbell JD, Kotloff KL, Sow SO, Tapia M, Keita MM, Keita T, et al. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Paediatr Infect Dis 2004;23:642-9.
62. Yaro S, Lourd M, Traore Y, Njanpop-Lafourcade BM, Sawadogo A, Sangare L, et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkino Faso. Clin Infect Dis 2006;45:693-700.
63. Kizito ME, Mworozi E, Ndugwa C, Serjeant GR. Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child 2007; 92:21-3.
64. Greengross P, Hickman M, Gill M, Dugan B, Davies SC. Outcomes of universal antenatal screening for haemoglobinopathies. J Med Screen 1999;6:3-10.